Company Filing History:
Years Active: 2022-2023
Title: Mohammad Azab: Innovator in Cancer Treatment
Introduction
Mohammad Azab is a notable inventor based in Pleasanton, CA (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Azab's work focuses on improving the efficacy of cancer therapies.
Latest Patents
One of his latest patents is titled "Low dose combination CDA substrate drug/cedazuridine with extended administration." This invention relates to methods and compositions for administering an effective amount of a CDA substrate drug and an effective amount of cedazuridine. In particular, the invention addresses methods for treating cancer, inhibiting degradation of a CDA substrate drug, and reducing DNA methylation in a subject in need thereof. The administration of these compounds aims to enhance therapeutic outcomes for patients.
Career Highlights
Throughout his career, Azab has worked with prominent companies in the pharmaceutical industry. He has been associated with Otsuka Pharmaceutical Company, Limited and Astex Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Some of his notable coworkers include Harold Keer and Aram Oganesian. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.
Conclusion
Mohammad Azab's contributions to cancer treatment through his patents demonstrate his commitment to advancing medical science. His innovative approaches have the potential to significantly impact patient care and treatment outcomes.